Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

<p>Abstract</p> <p>Background</p> <p>The EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study was an international, randomized, open-label, assessor-blinded, parallel-group study assessing the efficacy and tolerability of i...

Full description

Bibliographic Details
Main Authors: Bennett R, AL-Sabbagh A, Traboulsee A, Chang P, Li DKB
Format: Article
Language:English
Published: BMC 2008-04-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/8/11

Internet

http://www.biomedcentral.com/1471-2377/8/11

Similar Items